勃起不全の世界市場レポート 2025年

勃起不全市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.9％で37億8,000万米ドルに成長します。予測期間における成長の原動力は、心理的要因の増加、肥満や代謝異常の割合の増加、非侵襲的な勃起不全治療に対する需要の高まり、性の健康に関する患者の相談件数の増加、男性の健康を促進し、生活習慣に関連するリスク要因に対処する政府のイニシアチブの増加などが見込まれます。主な動向としては、勃起不全治療薬の電子薬局の拡大、陰茎インプラント技術の発展、勃起不全診断における技術革新、EDの根本原因をターゲットとした新規治療法の開発、より効果的なホスホジエステラーゼ5型阻害剤の導入などが挙げられます。

生活習慣病の有病率の増加が勃起不全市場の成長を促進すると予想されます。生活習慣病は主に、食生活の乱れ、運動不足、喫煙、過度のアルコール摂取などの不健康な習慣によって引き起こされます。これらの疾患の増加要因には、座りがちな行動の増加、食生活の乱れ、ストレス、不健康な習慣などが含まれます。勃起不全（ED）は、心血管系疾患や糖尿病を含む生活習慣病の早期指標となることが多く、適時の医療介入とより健康的な生活習慣の改善が重要であることを強調しています。例えば、2022年5月、英国の非営利団体である世界肥満連盟は、2030年までに世界で10億人（女性の5人に1人、男性の7人に1人）が肥満とともに生活すると予測されると報告しました。この数字は、2035年までに世界人口の51％に当たる40億人が過体重または肥満になると予想されています。したがって、生活習慣病有病率の増加は、勃起不全市場の成長を促進すると予想されます。

勃起不全市場の主要企業は、ED患者により身近で便利な治療選択肢を提供するため、市販（OTC）ジェルなどの革新的製品の開発に注力しています。このアプローチは、市場へのリーチを拡大し、満たされていない患者ニーズに対応することを目的としています。OTCジェルとは、処方箋なしで入手できる外用薬で、特定の症状を治療するために皮膚に直接塗布します。例えば、2024年9月、英国のコンシューマー・ヘルスケア企業であるHaleon plc社は、勃起不全用の市販ジェルとして初めてFDAに認可されたEroxonを発売しました。この画期的な製品は、非侵襲的で即効性のあるソリューションを提供し、患者の利便性を向上させるように設計されています。外用剤であるため内服薬が不要であり、潜在的な全身的副作用を軽減し、代替治療の選択肢を提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界勃起不全 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の勃起不全市場：成長率分析
• 世界の勃起不全市場の実績：規模と成長, 2019-2024
• 世界の勃起不全市場の予測：規模と成長, 2024-2029, 2034F
• 世界勃起不全総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の勃起不全市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬物
• デバイス
• 世界の勃起不全市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンラインチャンネル
• 世界の勃起不全市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 外来手術センター
• 薬局
• その他のエンドユーザー
• 世界の勃起不全市場、薬物の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ホスホジエステラーゼ5型（PDE5）阻害剤
• ホルモン療法
• 注射薬
• 外用薬
• 世界の勃起不全市場、デバイスの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 真空勃起装置（VED）
• 陰茎インプラント
• 衝撃波治療装置

第7章 地域別・国別分析

• 世界の勃起不全市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の勃起不全市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 勃起不全市場：競合情勢
• 勃起不全市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Dong-A Socio Holdings Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Eli Lilly and Company
• Viatris Inc.
• Teva Pharmaceutical Industries Limited
• Boston Scientific Corporation
• Sandoz International GmbH
• Sun Pharmaceutical Industries Limited
• Coloplast Corporation
• Dr. Reddy's Laboratories Limited
• Cipla Limited
• Ferring Pharmaceuticals A/S
• Endo International plc
• Zydus Lifesciences Limited
• Lupin Limited
• Hims & Hers Health Inc.
• Cadila Pharmaceuticals Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 勃起不全市場2029：新たな機会を提供する国
• 勃起不全市場2029：新たな機会を提供するセグメント
• 勃起不全市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Erectile dysfunction (ED) is the inability to achieve or sustain an erection adequate for satisfactory sexual performance. It is a prevalent condition influenced by physical, psychological, and lifestyle factors, impacting men's overall well-being and quality of life.

The primary product categories for erectile dysfunction include drugs and devices. Drugs are chemical formulations designed to improve blood flow to the penis, enabling men to attain and maintain an erection. These products are distributed through hospital pharmacies, retail pharmacies, and online channels, serving end users such as hospitals and clinics, ambulatory surgery centers, pharmacies, and other healthcare providers.

The erectile dysfunction market research report is one of a series of new reports from The Business Research Company that provides erectile dysfunction market statistics, including erectile dysfunction industry global market size, regional shares, competitors with an erectile dysfunction market share, detailed erectile dysfunction market segments, market trends and opportunities, and any further data you may need to thrive in the erectile dysfunction industry. This erectile dysfunction market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The erectile dysfunction market size has grown strongly in recent years. It will grow from $2.46 billion in 2024 to $2.69 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period was driven by the increasing incidence of cardiovascular diseases, the rising prevalence of diabetes, greater awareness of erectile dysfunction as a medical condition, an aging population contributing to higher ED cases, and a growing preference for personalized treatment options.

The erectile dysfunction market size is expected to see strong growth in the next few years. It will grow to $3.78 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period is expected to be driven by an increase in psychological factors, higher rates of obesity and metabolic disorders, rising demand for non-invasive erectile dysfunction treatments, a growing number of patient consultations for sexual health, and increasing government initiatives promoting men's health and addressing lifestyle-related risk factors. Key trends include the expansion of e-pharmacies for erectile dysfunction drugs, advancements in penile implant technologies, technological innovations in erectile dysfunction diagnostics, the development of novel treatment methods targeting the root causes of ED, and the introduction of more effective phosphodiesterase type 5 inhibitors.

The increasing prevalence of lifestyle-related diseases is expected to drive growth in the erectile dysfunction market. Lifestyle-related diseases are primarily caused by unhealthy habits such as poor diet, lack of physical activity, smoking, and excessive alcohol consumption. Factors contributing to the rise in these conditions include increased sedentary behavior, poor dietary choices, stress, and unhealthy habits. Erectile dysfunction (ED) is often an early indicator of lifestyle-related diseases, including cardiovascular conditions and diabetes, emphasizing the importance of timely medical intervention and healthier lifestyle changes. For example, in May 2022, the World Obesity Federation, a UK-based non-profit organization, reported that by 2030, one billion people worldwide equivalent to one in five women and one in seven men are projected to be living with obesity. This figure is expected to rise to four billion people, or 51% of the global population, who will be either overweight or obese by 2035. The increasing prevalence of lifestyle-related diseases is, therefore, expected to drive the growth of the erectile dysfunction market.

Leading companies in the erectile dysfunction market are focusing on developing innovative products, such as over-the-counter (OTC) gels, to provide more accessible and convenient treatment options for individuals with ED. This approach aims to expand market reach and address unmet patient needs. An OTC gel is a topical medication available without a prescription, applied directly to the skin to treat specific conditions. For instance, in September 2024, Haleon plc, a UK-based consumer healthcare company, introduced Eroxon, the first FDA-cleared over-the-counter gel for erectile dysfunction. This groundbreaking product offers a non-invasive, fast-acting solution designed to improve accessibility and convenience for patients. Its topical application eliminates the need for oral medications, reducing potential systemic side effects and providing an alternative treatment option.

In September 2022, Advanced MedTech Holdings, a Singapore-based medical device company, acquired Shenzhen Wikkon Medical Apparatus Co. Ltd. for an undisclosed amount. This acquisition strengthens Advanced MedTech Holdings' presence in the urology sector in China by leveraging Wikkon's expertise in developing and manufacturing urology and shock wave therapy devices. Shenzhen Wikkon Medical Apparatus Co. Ltd., a China-based company, specializes in extracorporeal shock wave therapy (ESWT) for treating conditions such as erectile dysfunction and urinary stones.

Major players in the erectile dysfunction market are Pfizer Inc., Bayer AG, Dong-A Socio Holdings Co. Ltd., Sanofi S.A., GlaxoSmithKline plc, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Limited, Boston Scientific Corporation, Sandoz International GmbH, Sun Pharmaceutical Industries Limited, Coloplast Corporation, Dr. Reddy's Laboratories Limited, Cipla Limited, Ferring Pharmaceuticals A/S, Endo International plc, Zydus Lifesciences Limited, Lupin Limited, Hims & Hers Health Inc., Cadila Pharmaceuticals Limited, VIVUS Inc., Rigicon Inc., Petros Pharmaceuticals Inc., Futura Medical plc, Apricus Biosciences Inc., Pos-T-Vac Medical Inc., Initiator Pharma A/S.

North America was the largest region in the erectile dysfunction market in 2024. The regions covered in erectile dysfunction report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the erectile dysfunction market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The erectile dysfunction market consists of sales of medications, devices, and therapies aimed at treating erectile dysfunction. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Erectile Dysfunction Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on erectile dysfunction market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for erectile dysfunction ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The erectile dysfunction market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Drugs; Devices
• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Channels
• 3) By End User: Hospitals And Clinics; Ambulatory Surgery Centers; Pharmacies; Other End Users
• Subsegments:
• 1) By Drugs: Phosphodiesterase Type 5 (PDE5) Inhibitors; Hormone Therapy; Injectable Medications; Topical Medications
• 2) By Devices: Vacuum Erection Devices (VEDs); Penile Implants; Shockwave Therapy Devices
• Companies Mentioned: Pfizer Inc.; Bayer AG; Dong-A Socio Holdings Co. Ltd.; Sanofi S.A.; GlaxoSmithKline plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Erectile Dysfunction Market Characteristics

3. Erectile Dysfunction Market Trends And Strategies

4. Erectile Dysfunction Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Erectile Dysfunction Growth Analysis And Strategic Analysis Framework

• 5.1. Global Erectile Dysfunction PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Erectile Dysfunction Market Growth Rate Analysis
• 5.4. Global Erectile Dysfunction Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Erectile Dysfunction Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Erectile Dysfunction Total Addressable Market (TAM)

6. Erectile Dysfunction Market Segmentation

• 6.1. Global Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drugs
• Devices
• 6.2. Global Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Channels
• 6.3. Global Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Ambulatory Surgery Centers
• Pharmacies
• Other End Users
• 6.4. Global Erectile Dysfunction Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Phosphodiesterase Type 5 (PDE5) Inhibitors
• Hormone Therapy
• Injectable Medications
• Topical Medications
• 6.5. Global Erectile Dysfunction Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vacuum Erection Devices (VEDs)
• Penile Implants
• Shockwave Therapy Devices

7. Erectile Dysfunction Market Regional And Country Analysis

• 7.1. Global Erectile Dysfunction Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Erectile Dysfunction Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Erectile Dysfunction Market

• 8.1. Asia-Pacific Erectile Dysfunction Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Erectile Dysfunction Market

• 9.1. China Erectile Dysfunction Market Overview
• 9.2. China Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Erectile Dysfunction Market

• 10.1. India Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Erectile Dysfunction Market

• 11.1. Japan Erectile Dysfunction Market Overview
• 11.2. Japan Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Erectile Dysfunction Market

• 12.1. Australia Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Erectile Dysfunction Market

• 13.1. Indonesia Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Erectile Dysfunction Market

• 14.1. South Korea Erectile Dysfunction Market Overview
• 14.2. South Korea Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Erectile Dysfunction Market

• 15.1. Western Europe Erectile Dysfunction Market Overview
• 15.2. Western Europe Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Erectile Dysfunction Market

• 16.1. UK Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Erectile Dysfunction Market

• 17.1. Germany Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Erectile Dysfunction Market

• 18.1. France Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Erectile Dysfunction Market

• 19.1. Italy Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Erectile Dysfunction Market

• 20.1. Spain Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Erectile Dysfunction Market

• 21.1. Eastern Europe Erectile Dysfunction Market Overview
• 21.2. Eastern Europe Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Erectile Dysfunction Market

• 22.1. Russia Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Erectile Dysfunction Market

• 23.1. North America Erectile Dysfunction Market Overview
• 23.2. North America Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Erectile Dysfunction Market

• 24.1. USA Erectile Dysfunction Market Overview
• 24.2. USA Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Erectile Dysfunction Market

• 25.1. Canada Erectile Dysfunction Market Overview
• 25.2. Canada Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Erectile Dysfunction Market

• 26.1. South America Erectile Dysfunction Market Overview
• 26.2. South America Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Erectile Dysfunction Market

• 27.1. Brazil Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Erectile Dysfunction Market

• 28.1. Middle East Erectile Dysfunction Market Overview
• 28.2. Middle East Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Erectile Dysfunction Market

• 29.1. Africa Erectile Dysfunction Market Overview
• 29.2. Africa Erectile Dysfunction Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Erectile Dysfunction Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Erectile Dysfunction Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Erectile Dysfunction Market Competitive Landscape And Company Profiles

• 30.1. Erectile Dysfunction Market Competitive Landscape
• 30.2. Erectile Dysfunction Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Dong-A Socio Holdings Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Erectile Dysfunction Market Other Major And Innovative Companies

• 31.1. Eli Lilly and Company
• 31.2. Viatris Inc.
• 31.3. Teva Pharmaceutical Industries Limited
• 31.4. Boston Scientific Corporation
• 31.5. Sandoz International GmbH
• 31.6. Sun Pharmaceutical Industries Limited
• 31.7. Coloplast Corporation
• 31.8. Dr. Reddy's Laboratories Limited
• 31.9. Cipla Limited
• 31.10. Ferring Pharmaceuticals A/S
• 31.11. Endo International plc
• 31.12. Zydus Lifesciences Limited
• 31.13. Lupin Limited
• 31.14. Hims & Hers Health Inc.
• 31.15. Cadila Pharmaceuticals Limited

32. Global Erectile Dysfunction Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Erectile Dysfunction Market

34. Recent Developments In The Erectile Dysfunction Market

35. Erectile Dysfunction Market High Potential Countries, Segments and Strategies

• 35.1 Erectile Dysfunction Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Erectile Dysfunction Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Erectile Dysfunction Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer